GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (NAS:QDEL) » Definitions » Price-to-Owner-Earnings

QuidelOrtho (QuidelOrtho) Price-to-Owner-Earnings : 18.63 (As of Apr. 25, 2024)


View and export this data going back to 1992. Start your Free Trial

What is QuidelOrtho Price-to-Owner-Earnings?

As of today (2024-04-25), QuidelOrtho's share price is $39.69. QuidelOrtho's Owner Earnings per Share (TTM) ended in Dec. 2023 was $2.13. It's Price-to-Owner-Earnings for today is 18.63.


The historical rank and industry rank for QuidelOrtho's Price-to-Owner-Earnings or its related term are showing as below:

QDEL' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.04   Med: 36.15   Max: 308.24
Current: 18.68

During the past 13 years, the highest Price-to-Owner-Earnings of QuidelOrtho was 308.24. The lowest was 4.04. And the median was 36.15.


QDEL's Price-to-Owner-Earnings is ranked better than
67.62% of 281 companies
in the Medical Devices & Instruments industry
Industry Median: 31.79 vs QDEL: 18.68

As of today (2024-04-25), QuidelOrtho's share price is $39.69. QuidelOrtho's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.16. Therefore, QuidelOrtho's PE Ratio for today is At Loss.

As of today (2024-04-25), QuidelOrtho's share price is $39.69. QuidelOrtho's EPS without NRI for the trailing twelve months (TTM) ended in was $3.37. Therefore, QuidelOrtho's PE Ratio without NRI for today is 11.79.

During the past 13 years, QuidelOrtho's highest PE Ratio without NRI was 1038.89. The lowest was 2.82. And the median was 31.08.


QuidelOrtho Price-to-Owner-Earnings Historical Data

The historical data trend for QuidelOrtho's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho Price-to-Owner-Earnings Chart

QuidelOrtho Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.81 13.89 8.62 8.23 34.68

QuidelOrtho Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.23 15.69 35.73 20.41 34.68

Competitive Comparison of QuidelOrtho's Price-to-Owner-Earnings

For the Medical Devices subindustry, QuidelOrtho's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Price-to-Owner-Earnings falls into.



QuidelOrtho Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

QuidelOrtho's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=39.69/2.13
=18.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QuidelOrtho  (NAS:QDEL) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


QuidelOrtho Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho (QuidelOrtho) Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Executives
Louise Brandy officer: SVP, Chief Information Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Patrick Klein officer: Chief Administrative Officer 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Christopher M Smith director 125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Edward L. Michael director 618 SHERIDAN SQUARE, EVANSTON IL 60202
William J. Ferenczy officer: SVP, Cardio/Metabolic Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Werner Kroll officer: SVP, Research and Development 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Kenneth F Buechler director
Robert R. Schmidt director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tamara A. Ranalli officer: SVP, Molecular Bus. Unit 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Stephen H. Wise director C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Robert Joseph Bujarski officer: See Remarks C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Wilkins Joseph D Jr. director 82414 PUCCINI DRIVE, INDIO CA 92203
Michelle A. Hodges officer: SVP, General Counsel 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Douglas C Bryant director, officer: Chairman & CEO C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Joseph M Busky officer: Chief Financial Officer 1717 DEERFIELD ROAD, DEERFIELD IL 60015